It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.
Canopy Growth Corp. has garnered the most attention and established itself as the market leader; however, there is another company in the Canadian marijuana industry that could emerge as a potential winner.
Canopy Growth’s recently acquired Mettrum Ltd. stated that it wrote off $800,000 of costs owing to a series of recalls over the use of a banned pesticides. The staff at Mettrum feared detection from authorities, so they hid the pesticides in the office’s ceiling tiles.
Since seeing all the buzz and craze these companies are causing in the marketplace, we’ve been hot on the trail of companies tied to the cannabis sector. The budding marijuana industry has spawned several high flying stocks lately, like Mentor Capital Inc.
Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.
The cannabis industry is expected to reach $50 billion in size by 2026, according to Cowen & Co., making it one of the fastest growing industries in the world. Investors have taken a growing interest in the industry as legalization has spread across North America. Here are three subsets of the cannabis industry that investors may want to consider for the best risk-adjusted returns.
Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
“We are continuing to see Canadian companies invest in or acquire assets in U.S. cannabis markets […] looking to take advantage of increased demand abroad,” a Viridian Capital analyst says.
Roto-Gro International, a Canadian cannabis-tech company has been admitted to the ASX, and has become the latest player to join the list of cannabis based companies on the ASX.
Canopy Growth Corporation’s generating eye-popping returns for investors. However, there are risks ahead that could rein in some investor optimism.
Marijuana prices are falling. Could marijuana stock prices drop soon, too?
On the face of it, 2017 may be the year to jump into the marijuana market to get a piece of what looks to be promising growth over the next few years.
As of Wednesday, traders on the Toronto Stock Exchange can buy and sell “WEED.”
A federal court in Boston last week entered judgments against a publicly traded company purportedly serving medical marijuana businesses over allegations that it defrauded investors by lying about the company’s true owner.
Florida is undeniably behind the curve when it comes to passing pro-pot legislation, but the Sunshine State did make up some ground in November, when voters legalized medical marijuana in the state. How big could the medical marijuana market be in Florida for marijuana stocks?
Forward-thinking investors are already plotting seven-figure weed windfalls with the top pot stocks from every ecosystem. You see, there’s more to the marijuana industry than just selling cannabis. There are a lot of ways to profit from legal recreational and medical marijuana sales.
Canadian weed? It’s supposed to be pretty good.But Arizona medical marijuana? Super profitable. Ask the people from a Toronto firm who recently announced the “acquisition” — with caveats and disclaimers — of two Mesa dispensaries.
Investing in cannabis stocks is being called the “gold rush” of the 21st century. That’s because legal marijuana sales in North America climbed to $6.7 billion in 2016.
Marijuana stocks may be in for a bumpy ride this year.
The market for marijuana is exploding as Americans overwhelmingly embrace legalization. Analysts are projecting tens of billions of dollars in future marijuana sales, making this an intriguing market for investors.
Marijuana sales has the potential to greatly add to government’s treasury as well, and it will be immensely helpful in medical fields. Nowadays, it is also easier for banks for provide services for legal marijuana businesses.
On Nov. 21, 2016, Kaya Holdings (OTCQB:KAYS), whose subsidiary Kaya Shack opened its first cannabis dispensary in Portland, Oregon, in 2014, announced that it had filed its third quarterly report of 2016, reporting a 700% year-over-year revenue increase.
On Nov. 3, 2016, Kush Bottles (OTCQB:KSHB), a supplier of packaging solutions and accessories for the legal cannabis industry, announced that it logged a record-breaking annual revenue of approximately $8.2 million for the fiscal year ended on Aug. 31.
New Cannabis Ventures broke the news Monday evening. It will be the first publicly-traded cannabis-related Real Estate Investor Trust or REIT and, if approved, would be the first cannabis company to be traded at the venerable NYSE.
Washington, D.C.-based startup New Frontier Data has almost completed a $5 million funding round to expand its work doing data and analytics for the legal marijuana industry.
On Sept. 26, 2016, GW Pharmaceuticals (Nasdaq:GWPH), a biopharma company with two promising cannabis-based medications, announced positive results for its third study in the United States on the efficacy of Epidiolex, its experimental CBD-based drug, in treating seizures associated with Lennox-Gastaut syndrome.
On Sept. 26, 2016, Massroots (OTCQB:MSRT) issued a letter from Isaac Dietrich, Chairman and Chief Executive Officer, on the company’s outlook for Fall 2016, including updates on the product pipeline, user growth and expense reductions, among others; however, the letter failed to address the company’s recent default on debt.
GreenLight Medicines, a pharmaceutical startup based in Ireland, has secured funding from a group of private Irish investors to create “breakthrough” medicines with cannabis extracts.
GW Pharmaceuticals Plc (Nasdaq:GWPH), a developer of marijuana-based epilepsy treatments, is working with an investment bank after other drugmakers approached it to express interest in an acquisition, people familiar with the matter said.
Med-X is a company I have been researching today that provides nontoxic and 100 percent all-natural pest management products to people who grow marijuana legally.
When three Colorado marijuana entrepreneurs made a presentation to 40 Silicon Valley investors last year, it was as though they were discussing something dirty.
Shares of Insys Therapeutics Inc. (NASDAQ:INSYS) soared 19% in premarket trade Tuesday.
Federal securities regulators have filed a complaint against Bruce Perlowin that charges the CEO of publicly-traded Hemp Inc of committing a long-running fraud by evading securities registration provisions and selling hundreds of millions of unregistered shares.
Crowdfunding seemed like the perfect solution for cannabis entrepreneur Ralf-Rainer von Albedyhll, CEO of NextRX Inc., based in Las Vegas, Nevada. He had tried the more traditional funding avenues with little success.
On May 24, 2016, MassRoots (OTCQB: MSRT), a social media app for cannabis enthusiasts, announced that NASDAQ denied the company’s application for listing on the NASDAQ Capital Market, which had been filed back in August 2015.
Medical-marijuana startup LeafLine Labs has begun an effort to raise $21 million, according to a regulatory filing.
On April 28, 2016, the U.S. Securities and Exchange Commission announced the temporary suspension of trading in Pineapple Express (OTC: PNPL) due to unusual market activity in the company’s securities. The suspension started at 9:30 a.m. EDT today and will end at 11:59 p.m. EDT on May 11.
On April 25, 2016, Organigram (TSX: OGI), a licensed producer for Health Canada’s Marihuana for Medical Purposes Regulations, announced that it had reported financial results for the second fiscal quarter of 2016.
On April 20, 2016, Chooze Corp. launched its first product, LucidMood, a line of vaporizable pucks infused with terpenes, distinctive aromatic compounds, that induce immediate shifts in the individual moods of those who have THC in their systems.
MassRoots, Inc., the ‘Facebook’ for cannabis consumers, is filing an offering to go public with hopes that the NASDAQ will approve them for a listing.
On April 5, 2016, Meadow, a medical cannabis delivery and software company based in San Francisco, announced that it had closed a $2.1 million round of seed funding.
While cannabis-focused startups are beginning to sprout all over the country as various forms of legalization are implemented, the District’s bizarre standard of having cannabis technically legal but unregulated is a fecund plot for creative businesses.
On April 4, 2016, Strainz Inc., a national cannabis brand management company, announced that it had raised $8 million, $6 million of which was raised through Series A funding from venture capital and angel investors.
On March 14, 2016, GW Pharmaceuticals (NASDAQ: GWPH), a biopharma company with two promising cannabis-based medications, announced positive results for the first pivotal Phase 3 study of Epidiolex, a CBD-based medicine, in treating Dravet syndrome, a severe form of pediatric epilepsy.
You can trade gold and pork belly futures, why not hemp?
On Jan. 20, 2016, Vireo Health, a medical marijuana holding company, filed Form D with the Securities and Exchange Commission, notifying the SEC of its exempt offering and sale of securities valued at $31.5 million under Rule 506(c).
On Dec. 31, 2015, Green Dragon Cannabis Co. opened a dispensary in Breckenridge, in what was formerly the Backcountry Cannabis Club.
With a $25,000 investment minimum, a total of 13 purchasers helped MJ Freeway close its $8 million round of Series B financing. On Dec. 21, the company officially announced the raise, identifying Roger McNamee and Tao Capital Partners as investors.
On Wednesday, Nov. 18, CanopyBoulder’s Fall 2015 class will host “CanopyBoulder Demo Day,” a presentation of nine pioneering startups that are now ready to pitch their companies to seasoned investors after an intensive 13-week business accelerator program.
While there has been a significant victory in Oregon to open up delivery services and challenges to the status quo are taking place in banking, the most promising development for everyday investors is the ongoing effort to open up the public markets to marijuana firms.